(Q42482272)

1 November 2017

title

Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update (English)

1 reference

1 November 2017

1 reference

1 reference

Myron John Tong

1

1 reference

1 November 2017

Leeyen Hsu

series ordinal

2

1 reference

1 November 2017

Patrick W Chang

series ordinal

3

1 reference

1 November 2017

Lawrence Mitchell Blatt

series ordinal

4

1 reference

1 November 2017

publication date

1 May 2011

1 reference

Journal of Gastroenterology and Hepatology

1 November 2017

published in

1 reference

1 November 2017

volume

26

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

829-835

1 reference

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

A proposed, evidence-based approach to the treatment of chronic Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06623.X

10.1111/J.1440-1746.2011.06623.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference